Back to Journals
ImmunoTargets and Therapy
Departments of Pathology and Immunology, University of Pittsburgh Medical Center, United States
Editor-in-Chief: Michael R Shurin
Michael R. Shurin, MD, PhD is a Professor of Pathology and Immunology at the University of Pittsburgh Medical Center and an associate director of the Division of Clinical Immunopathology. After graduation from medical school in Moscow and additional clinical training, Professor Shurin proceeded his research career in psychoneuroimmunology and obtained a PhD degree in immunopharmacology from the State Research Institute for Pharmacology in Moscow, Russia. From 1991, Michael Shurin was a member of the faculty at the University of Pittsburgh at the departments of surgery and pathology. He leads a unique research program focusing on cellular and molecular interactions in the tumor microenvironment supported by NIH and other foundations.
He is well known for his studies on dendritic cells in cancer. Professor Shurin has published more than 200 papers, reviews and book chapters, edited four books, including “The Tumor Immunoenvironment” and “Infection and Cancer: Bidirectorial Interactions”, organized several international conferences on immune-mediated diseases, immunodiagnostics and cancer immunotherapy. He served on NIH, DoD and ACS study session, several editorial boards and advisory committees.
Robert J. Amato, Professor of Oncology, Department of Internal Medicine, The University of Texas Health Science Centre at Houston, Houston, TX, USA
Natalia Aptsiauri, Department of Biochemistry, Molecular Biology III and Immunology, University of Granada Medical School, Spain
Gurkamal Chatta, Roswell Park Cancer Institute, Buffalo, NY, USA
Ramon Kaneno, Associate Professor and Head of the Department of Microbiology and Immunology, Institute of Biosciences of Botucatu - UNESP - Sao Paulo State University, Botucatu, SP, Brazil
Maciej Lesniak, Michael J. Marchese Professor and Chair, Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Yangqiu Li, Professor of Medicine and the Director of Institute of Hematology of Medical College, Jinan University, People's Republic of China
Azzam A. Maghazachi, Professor, College of Medicine, University of Sharjah, Sharjah, United Arabs Emirates
Kamal Moudgil, Professor, Department of Microbiology and Immunology, Division of Rheumatology, Department of Medicine, University of Maryland, School of Medicine, Baltimore, MD, USA
Federico Perche, CNRS Researcher, Cell Biology, Molecular Targets and Innovative Therapies, Centre for Molecular Biophysics, Orléans, France.
Franco Maria Venanzi, Professor in Physiology, School of Biosciences and Veterinary Medicine, University of Camerino (UNICAM), Camerino, Italy.
Richard Warrington, Professor of Medicine & Immunology at the University of Manitoba, Winnipeg, Canada
Theresa L. Whiteside, PhD, MDHC, Professor of Pathology, Immunology and Otolaryngology, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
Qizhi (Cathy) Yao, Professor, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA